MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmicb.2025.1492268

Медицинская библиотека · Frontiers in microbiology · 2025

Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis.

Yun Jin-Seung, Shin Eunkyung, Lee Young-Ran, Lee Jung-Ah, Lee Hyeokjin, Kim Jong-Seok, Shin Sung Jae, Ha Sang-Jun, Lee Sang-Won, Kim Dokeun, Yoo Jung-Sik, Jeong Hye-Sook

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

The inadequate efficacy of the Bacillus Calmette-Guérin (BCG) vaccine against adult pulmonary tuberculosis (TB) necessitates the development of new and effective vaccines. Human adenovirus serotype 5 (Ad5), which induces T-cell response, is a widely used viral vector. In this study, we aimed to evaluate the efficacy of a multi-antigenic recombinant Ad5 vectored vaccine and determine the optimal immunization route for enhanced immune response against Mycobacterium tuberculosis.

METHODS

We constructed a multi-antigenic recombinant Ad5 vectored vaccine expressing four antigens (Ag85B-ESAT6-MPT64-Rv2660c) of M. tuberculosis (rAd-TB4), immunized with rAd-TB4 (5 × 107 infectious virus units/mouse) twice at an interval of 4 weeks starting at 10 weeks after BCG priming, and evaluated its boosting efficacy in a BCG-primed mouse model, and determined the optimal immunization route.

RESULTS

Compared with the BCG-only (2 × 105 colony forming units/mouse), subcutaneous injection of rAd-TB4 (1 × 107 infectious virus units/mL; two doses) elicited a T-cell response and cytokine production in lung lymphocytes and splenocytes. rAd-TB4 immunization significantly reduced bacterial loads and inflamed lung areas compared to BCG immunization (p < 0.01) and protected against the H37Rv challenge performed at 17 weeks of BCG priming. RNA sequencing of the whole blood of rAd-TB4-vaccinated mice collected pre- and, 1 and 4 weeks post-infection, identified differentially expressed genes associated with immune and inflammatory responses, especially those in the Wnt signaling pathway.

CONCLUSION

Our results indicate that rAd-TB4 immunization enhances the immune response to the vaccine boosting antigens in BCG-primed mice, making it a potential adult pulmonary TB vaccine candidate.

Для цитирования: Yun Jin-Seung, Shin Eunkyung, Lee Young-Ran, Lee Jung-Ah, Lee Hyeokjin, Kim Jong-Seok, Shin Sung Jae, Ha Sang-Jun, Lee Sang-Won, Kim Dokeun, Yoo Jung-Sik, Jeong Hye-Sook. Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis.. Frontiers in microbiology. 2025. DOI: 10.3389/fmicb.2025.1492268.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.